These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Covalent binding to DNA in vitro of 2',3'-oxides derived from allylbenzene analogs. Luo G, Guenthner TM. Drug Metab Dispos; 1996 Sep; 24(9):1020-7. PubMed ID: 8886614 [Abstract] [Full Text] [Related]
3. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Randerath K, Haglund RE, Phillips DH, Reddy MV. Carcinogenesis; 1984 Dec; 5(12):1613-22. PubMed ID: 6499112 [Abstract] [Full Text] [Related]
4. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene. Lu LJ, Disher RM, Reddy MV, Randerath K. Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023 [Abstract] [Full Text] [Related]
5. Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs. Guenthner TM, Luo G. Toxicology; 2001 Mar 07; 160(1-3):47-58. PubMed ID: 11246123 [Abstract] [Full Text] [Related]
6. Formation and persistence of safrole-DNA adducts over a 10,000-fold dose range in mouse liver. Gupta KP, van Golen KL, Putman KL, Randerath K. Carcinogenesis; 1993 Aug 07; 14(8):1517-21. PubMed ID: 8102595 [Abstract] [Full Text] [Related]
7. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts. Balu N, Padgett WT, Nelson GB, Lambert GR, Ross JA, Nesnow S. Anal Biochem; 2006 Aug 15; 355(2):213-23. PubMed ID: 16797471 [Abstract] [Full Text] [Related]
8. Analysis of cytogenetic effects and DNA adduct formation induced by safrole in Chinese hamster lung cells. Daimon H, Sawada S, Asakura S, Sagami F. Teratog Carcinog Mutagen; 1997 Aug 15; 17(1):7-18. PubMed ID: 9249926 [Abstract] [Full Text] [Related]
11. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite. Randerath K, Moorthy B, Mabon N, Sriram P. Carcinogenesis; 1994 Oct 15; 15(10):2087-94. PubMed ID: 7955037 [Abstract] [Full Text] [Related]
13. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice. Phillips DH, Reddy MV, Randerath K. Carcinogenesis; 1984 Dec 15; 5(12):1623-8. PubMed ID: 6499113 [Abstract] [Full Text] [Related]
14. 32P-postlabeling analysis of DNA adducts formed by leukotriene A4 (LTA4). Funk D, Sorg BL, Lindner SC, Schmeiser HH. Environ Mol Mutagen; 2010 May 15; 51(4):338-43. PubMed ID: 20120015 [Abstract] [Full Text] [Related]
15. Inhibition of sulfotransferase affecting in vivo genotoxicity and DNA adducts induced by safrole in rat liver. Daimon H, Sawada S, Asakura S, Sagami F. Teratog Carcinog Mutagen; 2010 May 15; 17(6):327-37. PubMed ID: 9485541 [Abstract] [Full Text] [Related]
17. N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo. Phillips DH, Miller JA, Miller EC, Adams B. Cancer Res; 1981 Jul 15; 41(7):2664-71. PubMed ID: 7248936 [Abstract] [Full Text] [Related]